Differential co-localisation analysis of multi-sample and multi-condition experiments with spatialFDA

Advances in spatial omics data generation have led to an explosion in new datasets that record the spatial location of transcripts and proteins. However, challenges remain in the analysis of spatial omics data. One important analysis is differential cellular co-localisation (CCoL): the quantification of the clustering, or spacing, of one or more cell types across multiple conditions. Our framework spatialFDA combines methodology from spatial statistics with functional data analysis to accurately quantify and test for differences between conditions in CCoL across spatial scales. Using two simulation studies, we show that spatialFDA performs well in controlled settings. Furthermore, spatialFDA recovers known biological processes in type-1 diabetes and adds insights about the CCoL strength in space. spatialFDA is readily available as an open-source Bioconductor R package.